Standard BioTools (LAB) vs Nautilus Biotechnology (NAUT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Nautilus Biotechnology (NAUT) has outperformed Standard BioTools (LAB) over the past year, gaining 126.3% versus a loss of 47.8%. Over five years, NAUT leads with a -65.7% price change compared with -87.3% for LAB. Standard BioTools is the larger company by market cap ($263.1 million vs $231.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LAB | NAUT |
|---|---|---|
| Share price | $0.6703 | $1.82 |
| Market cap | $263.15M | $231.60M |
| 1-day change | -1.24% | -7.14% |
| YTD return | -46.98% | +0.51% |
| 1-year return | -47.79% | +126.33% |
| 5-year return | -87.29% | -65.67% |
| EPS (TTM) | $-0.13 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.72 | $4.31 |
| 52-week low | $0.63 | $0.82 |
| Distance from 52-week high | -61.03% | -57.77% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +101.40% | +110.44% |
| Average volume | 1.57M | 2.59M |
| Shares outstanding | 392.58M | 127.26M |
| Employees | 385 | 127 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NAUT has outperformed LAB by 174.1 percentage points over the past year.
About Standard BioTools
LAB stock →Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.
Industrials · Biotechnology: Laboratory Analytical Instruments · 385 employees
About Nautilus Biotechnology
NAUT stock →Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.
Industrials · Biotechnology: Laboratory Analytical Instruments · 127 employees
LAB vs NAUT FAQ
Which is bigger, Standard BioTools or Nautilus Biotechnology?
Standard BioTools (LAB) is larger, with a market capitalization of $263.15M compared with $231.60M for Nautilus Biotechnology (NAUT).
Which stock has performed better over the past year, LAB or NAUT?
NAUT returned +126.33% over the past 12 months, compared with -47.79% for LAB (price return, excluding dividends). Past performance does not predict future results.
Are Standard BioTools and Nautilus Biotechnology in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.